Executive Overview: Corporate Governance and Conflict-of-Interest Regulation under Section 188
In corporate jurisprudence, transactions between a company and its promoters, directors, key managerial personnel, or their relatives represent the primary vulnerability through which corporate assets can be transferred, profits diverted, and minority shareholders prejudiced. To prevent self-dealing, transfer pricing manipulation, and fiduciary breaches, the Parliament enacted Section 188 of the Companies Act, 2013 (replacing Section 297 of the Companies Act, 1956), read with the Companies (Meetings of Board and its Powers) Rules, 2014. Section 188 establishes an exhaustive, highly regulated governance framework governing contracts or arrangements with "related parties" across seven distinct commercial categories.
Unlike routine business agreements that require only operational approval, related party transactions (RPTs) are subject to a multi-tiered statutory gauntlet: (i) mandatory prior approval from the Audit Committee under Section 177 (including structured omnibus approvals); (ii) prior approval by the Board of Directors at a physical or video-convened meeting (where interested directors cannot vote); (iii) prior approval by the Shareholders by Ordinary Resolution where specified monetary thresholds (10% of annual turnover or net worth) are breached; and (iv) comprehensive statutory disclosure in the Board's Report in Form AOC-2 under Section 134(3)(h). However, Section 188 contains a critical, powerful statutory safe harbour: the fourth proviso exempts transactions entered into by the company in its ordinary course of business, provided they are conducted on an arm's length basis! Corporate secretarial heads, general counsels, and statutory auditors leveraging assureOffice and its corporate secretarial suite assurePractice must master the intricate definition of related parties under Section 2(76), the two-pillar arm's length defense, SEBI LODR Regulation 23 cross-linkages, CARO 2020 Clause (xiii) reporting, and voidability consequences under Section 188(3) to protect corporate transactions from invalidation and penal prosecution.
Statutory Definition of "Related Party" under Section 2(76) of the Companies Act, 2013
The applicability of Section 188 is anchored strictly to the definition of a "related party" codified under Section 2(76) of the Act. An entity or person is a related party with reference to a company if that person or entity is:
- Directors & Key Managerial Personnel (KMP): A director or his relative; a key managerial personnel (Managing Director, CEO, Whole-Time Director, CFO, Company Secretary) or his relative.
- Firms with Director Interest: A firm in which a director, manager, or his relative is a partner.
- Private Companies with Director Interest: A private company in which a director or manager is a director or member. (Notice: Even holding 1 share makes the private company a related party!).
- Public Companies with Significant Director Shareholding: A public company in which a director or manager is a director AND holds along with his relatives more than two per cent (2%) of its paid-up share capital.
- Entities Influenced by Board Advice: Any body corporate whose Board of Directors, managing director, or manager is accustomed to act in accordance with the advice, directions, or instructions of a director or manager (excluding professional advice).
- Persons on Whose Advice the Board Acts: Any person on whose advice, directions, or instructions a director or manager is accustomed to act (excluding professional advice).
- Holding, Subsidiary, and Fellow Subsidiaries (Rule 3):
- A holding, subsidiary, or an associate company of such company;
- A subsidiary of a holding company to which it is also a subsidiary (fellow subsidiary); and
- An investing company or the venturer of a company.
Secretarial teams utilizing assurePractice can automate the maintenance of digital related party master registers (Form MBP-1), instantly flagging transactions with conflicted entities.
Covered Transactions and the Monetary Thresholds under Rule 15
Section 188(1) explicitly enumerates seven specific categories of contracts or arrangements that fall within its statutory net. Under Rule 15(3) of the Meetings of Board Rules, where a transaction is NOT in the ordinary course of business or NOT on an arm's length basis, it requires prior approval of shareholders by Ordinary Resolution if it exceeds the following prescribed monetary thresholds:
| Clause | Category of Related Party Contract / Arrangement | Shareholder Approval Monetary Threshold (Rule 15(3)) |
|---|---|---|
| 188(1)(a) | Sale, purchase or supply of any goods or materials, directly or through appointment of agent. | Amounts to ten per cent (10%) or more of the annual turnover of the company. |
| 188(1)(b) | Selling or otherwise disposing of, or buying, property of any kind, directly or through appointment of agent. | Amounts to ten per cent (10%) or more of the net worth of the company. |
| 188(1)(c) | Leasing of property of any kind. | Amounts to ten per cent (10%) or more of the annual turnover of the company. |
| 188(1)(d) | Availing or rendering of any services, directly or through appointment of agent. | Amounts to ten per cent (10%) or more of the annual turnover of the company. |
| 188(1)(e) | Appointment of any agent for purchase or sale of goods, materials, services or property. | Limits specified under clauses (a), (b), or (d) respectively. |
| 188(1)(f) | Such related party's appointment to any office or place of profit in the company, its subsidiary or associate company. | Monthly remuneration exceeding two and a half lakh rupees (₹2,50,000). |
| 188(1)(g) | Underwriting the subscription of any securities or derivatives thereof of the company. | Remuneration exceeding one per cent (1%) of the net worth of the company. |
Calculation Benchmark: The turnover or net worth referred to above is computed based on the audited financial statements of the preceding financial year. The limits apply to transactions entered into individually or taken together with previous transactions during a financial year.
The "Ordinary Course of Business" and "Arm's Length" Statutory Safe Harbour (Fourth Proviso)
The single most powerful operational defense in corporate practice is codified in the fourth proviso to Section 188(1):
"Provided also that nothing in this sub-section shall apply to any transactions entered into by the company in its ordinary course of business other than transactions which are not on an arm's length basis."
If a transaction satisfies BOTH prongs of this test, neither Board approval under Section 188 nor Shareholder approval is required!
1. The "Ordinary Course of Business" Test
While the Companies Act does not define "ordinary course of business", established company law jurisprudence and ICAI Guidance Notes establish key benchmarks:
- Is the activity part of the regular, day-to-day, normal commercial operational activities of the company?
- Is the activity covered under the Main Objects Clause of the Memorandum of Association (MOA)?
- Is there historical frequency, volume, and continuity of such transactions with other independent third parties?
- Exceptional, non-recurring transactions (e.g., selling a company's corporate head office, transferring an entire manufacturing division, or granting speculative high-risk loans) can NEVER be treated as entered into in the ordinary course of business!
2. The "Arm's Length Basis" Test
Explanation (b) to Section 188(1) defines: "the expression 'arm's length transaction' means a transaction between two related parties that is conducted as if they were unrelated, so that there is no conflict of interest."
To substantiate that a transaction is at arm's length, the company must benchmark its terms against standard market metrics: (a) comparable uncontrolled prices (CUP) charged to or by third-party vendors; (b) standard price lists and credit periods; (c) competitive independent commercial bids; or (d) formal valuation reports from an IBBI-Registered Valuer or transfer pricing documentation under Section 92D of the Income-tax Act. Corporate finance teams utilizing assureTP maintain robust transfer pricing benchmarking files to defend the arm's length character of all intra-group supplies.
Audit Committee Oversight (Section 177) and Omnibus Approvals
Regardless of whether a transaction qualifies for the arm's length safe harbour under Section 188, under Section 177(4)(iv) of the Companies Act, 2013, EVERY related party transaction (and any subsequent modification) must be approved by the Audit Committee!
The Omnibus Approval Mechanism (Rule 6A)
To prevent operational paralysis in conglomerates where repetitive RPTs occur daily, the Audit Committee can grant Omnibus Approval for related party transactions subject to strict statutory conditions:
- The Audit Committee shall lay down the criteria for granting omnibus approval in line with the RPT policy, considering the repetitive nature and justification.
- The omnibus approval shall specify: (a) name of the related party; (b) nature and duration of transaction; (c) maximum amount of transaction; (d) indicative base price/formula; and (e) other conditions.
- Unforeseen Transactions: Where the need for an RPT cannot be foreseen and details are not available, omnibus approval can be granted subject to a value not exceeding ₹1 Crore per transaction.
- One-Year Validity: Omnibus approvals shall be valid for a period not exceeding one financial year and require fresh approval after the expiry of such year.
- Quarterly Review: The Audit Committee must review the details of RPTs entered into pursuant to omnibus approvals on a quarterly basis.
Corporate secretarial teams track omnibus utilization limits and quarterly review calendars using assurePractice.
Practical Case Studies and Numerical Illustrations
The following eight comprehensive real-world case studies illustrate complex scenarios encountered by corporate secretarial practitioners, legal counsels, and statutory auditors under Section 188.
Case Study 1: Commercial Raw Material Supply Contract Exceeding 10% Turnover Threshold
Facts: Vertex Pharma Ltd. (an unlisted public company: FY 2024-25 turnover = ₹200 Crores) proposes to purchase active pharmaceutical ingredients (APIs) worth ₹35,00,00,000 during FY 2025-26 from ChemSyn Organics Pvt. Ltd. ChemSyn is a private company in which two directors of Vertex Pharma are directors and hold 45% shares. Vertex procures identical APIs from unrelated suppliers at ₹1,000/kg; ChemSyn agrees to supply them at the identical price of ₹1,000/kg with standard 30-day payment terms.
Step-by-Step Statutory Analysis:
- Related Party Identification: Under Section 2(76)(iv), ChemSyn is a private company in which directors of Vertex are directors and members. ChemSyn is definitively a Related Party.
- Threshold Evaluation: Turnover of Vertex Pharma (Preceding FY 2024-25) = ₹200 Crores 10% Statutory Ceiling under Rule 15(3)(a) = ₹20 Crores Proposed Annual Purchases = ₹35 Crores (Exceeds 10% threshold!).
- Application of Fourth Proviso (Safe Harbour):
- Is it in the Ordinary Course of Business? Yes, purchasing raw materials for manufacturing pharmaceuticals is the core daily business activity of Vertex.
- Is it at Arm's Length? Yes, ChemSyn is supplying at ₹1,00,000 / 100 = ₹1,000/kg, which is identical to prices charged by unrelated third-party suppliers, supported by third-party purchase orders.
- Verdict: Because the transaction is in the ordinary course of business AND on an arm's length basis, the fourth proviso applies! No Board approval under Section 188 and NO Shareholder approval by Ordinary Resolution is required!
- Surviving Governance Requirement: Section 177(4)(iv) is NOT exempt. The Audit Committee of Vertex Pharma must approve the transaction (or grant omnibus approval). Furthermore, disclosure in notes to accounts under Ind AS 24 is mandatory. assurePractice automatically generates the Audit Committee omnibus approval memo.
Case Study 2: Disposal of Corporate Real Estate (Not in Ordinary Course of Business)
Facts: Synergy Infotech Ltd. (Net Worth as of 31st March 2025 = ₹80 Crores) owns a prime commercial office building in Bengaluru with a book value of ₹12 Crores. Due to corporate downsizing, the Board decides to sell the building to Horizon Infratech LLP (a partnership firm in which the Managing Director of Synergy is a 50% partner) for ₹15 Crores. An independent registered valuer confirms that the fair market value of the building is ₹15 Crores.
Statutory Analysis & Shareholder Resolution Mandate:
- Related Party Status: Under Section 2(76)(iii), a firm in which a director is a partner is a related party.
- Threshold Evaluation under Rule 15(3)(b): Selling property of any kind exceeding 10% of net worth. Net Worth = ₹80 Crores 10% Threshold = ₹8 Crores Transaction Value = ₹15 Crores (Exceeds 10% net worth ceiling!).
- Failure of Ordinary Course of Business: Synergy Infotech is a software technology company, not a real estate developer. Selling its corporate office is an exceptional, capital transaction that is NOT in the ordinary course of business!
- Statutory Requirement: Even though the sale is at arm's length (fair market value of ₹15 Cr supported by valuer report), the fourth proviso FAILS because the ordinary course test is not satisfied!
- Mandatory Approvals:
- Prior approval of the Audit Committee under Section 177;
- Prior approval of the Board of Directors under Section 188(1)(b) (the Managing Director cannot participate or vote); AND
- Prior approval of the Shareholders by ORDINARY RESOLUTION in a general meeting under Section 188(3)! The Managing Director and his relatives cannot vote on this resolution.
Case Study 3: Appointment to Office or Place of Profit Exceeding ₹2.5 Lakhs/Month (Section 188(1)(f))
Facts: BioHealth Laboratories Ltd. (a listed public company) proposes to appoint Ms. Ananya Sen (daughter of Mr. K. Sen, the Executive Chairman) as "Vice President - Clinical Alliances" at a gross monthly remuneration of ₹6,50,000 (annual CTC ₹78,00,000). Ms. Sen holds a Master's degree in Biotechnology from Johns Hopkins University.
Compliance Architecture under Section 188(1)(f) & Rule 15(3)(b):
- Definition of Office or Place of Profit (Explanation to Section 188(1)): An office or place of profit is held by a relative of a director if such relative receives from the company anything by way of remuneration, salary, perquisites, or commission over and above what they are entitled to as a normal employee.
- Threshold Evaluation: Under Rule 15(3)(b), appointment to any office or place of profit in the company at a monthly remuneration exceeding ₹2,50,000 mandates prior shareholder approval! Proposed Remuneration = ₹6,50,000 per month (> ₹2,50,000 statutory limit).
- Mandatory Approvals:
- Nomination and Remuneration Committee (NRC) approval under Section 178;
- Audit Committee approval under Section 177;
- Board of Directors approval under Section 188(1)(f) (Chairman Mr. Sen abstains); AND
- Shareholder approval by Ordinary Resolution at a general meeting before Ms. Sen assumes office!
Case Study 4: Consequences of Failure to Obtain Board Approval and Section 188(3) Ratification Window
Facts: On 10th May 2025, the Chief Operating Officer of Orion Logistics Ltd. executed an equipment lease agreement for ₹3,00,00,000 with Apex Transport Equipment LLP (a firm owned by the COO's brother). The transaction was not at arm's length and was executed without prior approval of the Board of Directors or Audit Committee. The default was detected by the internal auditor on 15th July 2025.
Statutory Consequence under Section 188(3):
- The 3-Month Ratification Window: Under Section 188(3), where any contract or arrangement is entered into by a director or any other employee, without obtaining the consent of the Board or approval by a resolution in the general meeting, and if it is NOT ratified by the Board or, as the case may be, by the shareholders at a meeting within THREE MONTHS from the date on which such contract or arrangement was entered into, such contract or arrangement shall be VOIDABLE at the option of the Board or, as the case may be, of the shareholders!
- Timeline Check: Contract Date: 10th May 2025. 3-Month Expiry Date: 10th August 2025.
- Action: The Board convenes an urgent meeting on 28th July 2025. The Board evaluates the contract and determines that it prejudiced the company. The Board refuses to ratify the contract.
- Personal Indemnity under Section 188(3): Because the contract was not ratified within 3 months:
- The contract becomes completely void and stands terminated;
- If the contract is with a related party to any director, or is authorized by any other director, the director concerned shall INDEMNIFY the company against any loss incurred by it!
- The company institutes recovery proceedings against the COO and his brother to recover ₹45 Lakhs in excess lease rentals paid.
Case Study 5: Disclosures in Board's Report in Form AOC-2 (Section 134(3)(h))
Facts: During FY 2025-26, Zenith Solar Energy Ltd. entered into two major related party transactions: (a) Procurement of solar cells worth ₹50 Crores from its subsidiary under ordinary course and arm's length; and (b) Sale of industrial land worth ₹18 Crores to an entity owned by its promoter, which was NOT in the ordinary course of business and was approved by shareholders by Ordinary Resolution.
Form AOC-2 Disclosure Delineation:
- Statutory Mandate: Under Section 134(3)(h) read with Rule 8(2) of the Companies (Accounts) Rules, 2014, the Board's Report must include a disclosure of particulars of contracts or arrangements with related parties in Form AOC-2.
- Structure of Form AOC-2:
- Part 1: Details of contracts or arrangements or transactions NOT at arm's length basis: Transaction (b) (Sale of land for ₹18 Cr) must be fully disclosed here, detailing: name of related party, nature of relationship, duration, salient terms, justification for entering into contract, date of board approval, date of shareholder approval, and advance payments.
- Part 2: Details of MATERIAL contracts or arrangements or transactions at arm's length basis: Under Section 188(1), arm's length contracts in the ordinary course do not require Section 188 board approval. However, if a contract is "material" under the company's RPT policy (or SEBI LODR for listed entities), it must be reported in Part 2 of Form AOC-2. Transaction (a) is reported in Part 2. Secretarial teams auto-populate Form AOC-2 using assurePractice.
Case Study 6: Interlocking Reporting under CARO 2020 Clause (xiii)
Facts: During the statutory audit of Delta Heavy Engineering Ltd., the statutory auditor discovered that the company paid management consultancy fees of ₹4,00,00,000 to a foreign partnership firm in which the Chairman was a partner. The transaction was neither at arm's length nor approved by the Audit Committee, and was omitted from Form AOC-2.
Auditor Reporting under CARO 2020:
- CARO 2020 Clause (xiii) Mandate: The auditor must report: "whether all transactions with the related parties are in compliance with sections 177 and 188 of Companies Act where applicable and the details have been disclosed in the financial statements etc., as required by the applicable accounting standards."
- Adverse Reporting: The statutory auditor issues severe qualifications in the CARO report, stating that: (a) Section 177 was violated due to absence of Audit Committee approval; (b) Section 188 was violated due to non-arm's length pricing without board/shareholder approval; and (c) Section 134(3)(h) was violated due to omission in Form AOC-2.
- MCA Scrutiny: The adverse CARO qualification triggers an automated inquiry from the Registrar of Companies under Section 206, leading to adjudication penalties under Section 188(5). Corporate governance workflows in assurePractice prevent these cross-statutory audit disasters.
Case Study 7: SEBI LODR Regulation 23 vs. Companies Act Section 188 (The Listed Company Conflict)
Facts: BluePeak Technologies Ltd. is a company listed on the National Stock Exchange (NSE). In FY 2025-26, its consolidated annual turnover is ₹1,000 Crores. The company proposes to enter into a software development service contract with a related party for ₹120 Crores. The transaction is in the ordinary course of business and on an arm's length basis.
Dual-Regime Regulatory Clash:
- Companies Act Section 188 Position: Because the contract is in the ordinary course of business AND at arm's length, the fourth proviso applies. Under the Companies Act, NO Shareholder approval is required.
- SEBI LODR Regulation 23 Position: Under Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a transaction is deemed "Material" if it exceeds ₹1,000 Crores OR 10% of annual consolidated turnover of the listed entity, whichever is LOWER! 10% of Consolidated Turnover = ₹100 Crores Proposed Transaction = ₹120 Crores (Exceeds ₹100 Cr threshold!). Crucially, unlike the Companies Act, SEBI LODR PROVIDES NO EXEMPTION FOR ORDINARY COURSE OR ARM'S LENGTH TRANSACTIONS!
- Verdict: Even though exempt under the Companies Act, BluePeak MUST obtain prior shareholder approval by Ordinary Resolution under SEBI LODR Regulation 23(4) before executing the contract! No related party can vote on the resolution. Ignoring SEBI LODR leads to severe stock exchange trading halts and SEBI enforcement actions.
Case Study 8: Statutory Penalties under Section 188(5) for Unapproved RPTs
Facts: The Managing Director of Nova Infrastructure Ltd. authorized an unsecured advance of ₹5,00,00,000 to his proprietary business without board or shareholder approval. The advance became a bad debt. The ROC initiated adjudication proceedings under Section 454 for violation of Section 188.
Penal Mathematics under Section 188(5):
- Statutory Penalty Framework: Any director or any other employee of a company who had entered into or authorized the contract or arrangement in violation of Section 188 shall:
- In case of a Listed Company: Be liable to a penalty of twenty-five lakh rupees (₹25,00,000);
- In case of Any Other Company: Be liable to a penalty of five lakh rupees (₹5,00,000).
- Disqualification of Director under Section 164(1)(g): Under Section 164(1)(g), a person who has been convicted of the offence dealing with related party transactions under Section 188 at any time during the last preceding five years is statutorily disqualified from being appointed as a director of any company!
- Corporate Recovery under Section 188(4): The company files a recovery suit against the Managing Director, securing a decree attaching his personal assets to recover the ₹5 Crore loss under Section 188(4). Corporate legal teams use assurePractice to enforce strict pre-authorization gates on all director disbursements.
10-Step Audit Verification Matrix for Section 188 RPT Compliance
Secretarial auditors issuing Form MR-3, statutory auditors reviewing CARO 2020 Clause (xiii), and corporate legal counsels must follow a structured verification program. The following 10-step matrix details the audit verification protocol:
| Step | Audit Dimension | Verification Protocol & Substantive Testing | Compliance Deliverable |
|---|---|---|---|
| 1 | Related Party Master Census | Extract Form MBP-1 general notices of interest from all directors and KMPs. Compile exhaustive Related Party Master under Section 2(76). | Master Related Party Register |
| 2 | Transaction Extraction & Matching | Scan all purchase, sales, service, lease, asset transfer, and consultancy ledgers. Match transaction counterparties against the RPT master. | RPT Transaction Ledger Schedule |
| 3 | Audit Committee Approval Audit | Verify prior approval from the Audit Committee for 100% of RPTs under Section 177. Review omnibus approval conditions and quarterly reviews. | Audit Committee Approval Dossier |
| 4 | Ordinary Course of Business Test | Evaluate whether transactions fall within the company's normal operating business, MOA main objects, and routine commercial practice. | Ordinary Course Assessment Memo |
| 5 | Arm's Length Benchmark Testing | Examine independent valuation reports, transfer pricing studies, competitive vendor quotes, and standard price lists under Explanation (b). | Arm's Length Substantiation File |
| 6 | Rule 15(3) Threshold Computation | Compute 10% of preceding year audited turnover or net worth. Compare individual and aggregate RPT values against statutory thresholds. | Rule 15(3) Threshold Workpaper |
| 7 | Board Meeting Voting & Minutes | Verify Board minutes for Section 188 approvals. Confirm interested directors disclosed interest and physically abstained from participating. | Board Approval & Voting Minutes |
| 8 | General Meeting & Resolution Scrutiny | Where thresholds were breached, verify that an Ordinary Resolution was passed in general meeting and interested members abstained from voting. | Shareholder Resolution & MGT-14 File |
| 9 | Form AOC-2 Disclosure True-Up | Draft and verify particulars of contracts in Form AOC-2 annexed to the Board's Report under Section 134(3)(h), reconciling with Ind AS 24. | Verified Form AOC-2 Disclosure Note |
| 10 | CARO 2020 Clause (xiii) Sign-Off | Cross-verify all findings against CARO Clause (xiii) requirements and assemble digital audit workpapers in assurePractice. | CARO Clause (xiii) Compliance Docket |
Statutory Disclosures in Form AOC-2 and Secretarial Automation via assurePractice
Form AOC-2 is the ultimate statutory disclosure instrument that bridges internal corporate governance with public transparency under Section 134(3)(h):
- Part 1 (Contracts Not at Arm's Length): Must contain detailed factual descriptions of non-arm's length or non-ordinary course transactions, including dates of board and shareholder approvals, duration, consideration, and management justification.
- Part 2 (Material Arm's Length Contracts): Discloses material ordinary course contracts, establishing total alignment with accounting standards (Ind AS 24 / AS 18) and SEBI regulations.
By leveraging assurePractice, corporate secretarial teams can automate the end-to-end management of Section 188 governance, maintain digital Form MBP-1 registers, track 10% turnover thresholds, auto-populate Form AOC-2, and eliminate Section 188(5) penalty risks across multi-entity corporate groups.
Frequently Asked Questions (FAQs) for Corporate Practitioners
Below are 16 detailed, practitioner-grade answers to the most common legal, operational, and procedural questions regarding Section 188 Related Party Transactions:
Q1: Does a transaction in the ordinary course of business and on an arm's length basis require Board approval under Section 188?
Answer: No. Under the fourth proviso to Section 188(1), transactions entered into in the ordinary course of business on an arm's length basis are completely exempt from Section 188 (no Board approval and no Shareholder approval required). However, prior approval of the Audit Committee under Section 177 remains mandatory.
Q2: Does Section 188 apply to transactions between a holding company and its wholly-owned subsidiary?
Answer: Under the fifth proviso to Section 188(1), the requirement of passing a resolution by the shareholders does NOT apply to transactions entered into between a holding company and its wholly-owned subsidiary whose accounts are consolidated and placed before shareholders for approval.
Q3: Can an interested director be present or vote at a Board meeting considering a Section 188 resolution?
Answer: Under Rule 15(2) of the Meetings of Board Rules, an interested director shall NOT be present at the meeting during the discussions and cannot vote on the resolution sanctioning the related party transaction.
Q4: What is the maximum validity period for an Omnibus Approval granted by the Audit Committee?
Answer: Under Rule 6A of the Meetings of Board Rules, an omnibus approval granted by the Audit Committee is valid for a period not exceeding one financial year and requires fresh approval after the expiry of such year.
Q5: What is the statutory threshold for shareholder approval for purchase or sale of goods under Section 188?
Answer: Under Rule 15(3)(a), shareholder approval by Ordinary Resolution is required if the contract for sale, purchase, or supply of goods amounts to ten per cent (10%) or more of the annual turnover of the company (based on preceding year audited financials).
Q6: Does Section 188 apply to a private limited company transacting with its holding or subsidiary company?
Answer: By virtue of the MCA Exemption Notification dated 5th June 2015, clause (viii) of Section 2(76) (holding, subsidiary, fellow subsidiary) does NOT apply to a private company for the purposes of Section 188. Hence, such intra-group transactions in a private company are exempt from Section 188.
Q7: Can related party shareholders vote on a Section 188 shareholder resolution?
Answer: Under the second proviso to Section 188(1), no member of the company who is a related party shall vote on such resolution to approve any contract or arrangement which may be entered into by the company. (Exemption applies if 90% or more members are relatives/promoters).
Q8: What is the monetary threshold for an unforeseen transaction under Audit Committee omnibus approval?
Answer: Under Rule 6A, for unforeseen transactions where specific details are not available, the Audit Committee may grant omnibus approval subject to their value not exceeding ₹1 Crore per transaction.
Q9: What happens if an unapproved RPT is not ratified within 3 months?
Answer: Under Section 188(3), if a contract is not ratified by the Board or shareholders within three (3) months from the date of entering into it, the contract becomes VOIDABLE at the option of the Board or shareholders, and the concerned director must indemnify the company against any loss.
Q10: Where are related party transactions disclosed in the annual report?
Answer: Related party transactions are disclosed in the Board's Report in Form AOC-2 under Section 134(3)(h), and in the Notes to Accounts under applicable Accounting Standards (Ind AS 24 / AS 18).
Q11: What is the monetary threshold for appointing a relative to an office or place of profit?
Answer: Under Rule 15(3)(b), appointment of a related party to an office or place of profit at a monthly remuneration exceeding ₹2,50,000 mandates prior shareholder approval by Ordinary Resolution.
Q12: What is the penalty under Section 188(5) for a listed company for non-compliance?
Answer: Any director or employee who entered into or authorized an unapproved RPT in a listed company is liable to a penalty of twenty-five lakh rupees (₹25,00,000) under Section 188(5).
Q13: Does conviction under Section 188 disqualify a person from being a director?
Answer: Yes. Under Section 164(1)(g), a person convicted of the offence dealing with related party transactions under Section 188 at any time during the preceding five years is statutorily disqualified from being appointed as a director of any company.
Q14: Does SEBI LODR Regulation 23 grant exemption for arm's length related party transactions?
Answer: No. Unlike the Companies Act, SEBI LODR Regulation 23 provides NO exemption for ordinary course or arm's length transactions. For listed entities, any material RPT (> ₹1,000 Cr or 10% consolidated turnover) mandatorily requires prior shareholder approval.
Q15: How is "Net Worth" computed for Section 188 leasing and property disposal thresholds?
Answer: Under Section 2(57), Net Worth is the aggregate value of paid-up share capital and free reserves and securities premium, after deducting accumulated losses, deferred expenditure, and unwritten-off miscellaneous expenses, as per the preceding year's audited balance sheet.
Q16: How does assurePractice automate Section 188 RPT compliance?
Answer: assurePractice provides an automated corporate governance platform: it compiles Section 2(76) related party master databases from Form MBP-1 notices, tracks 10% turnover/net worth thresholds, manages Audit Committee omnibus approvals and quarterly reviews, generates Form AOC-2 disclosure notes, and integrates with assureFinancials to ensure clean CARO 2020 Clause (xiii) certifications.